Literature DB >> 21801963

Impaired contractile response of human peripheral arterioles to thromboxane A-2 after cardiopulmonary bypass.

Jun Feng1, Yuhong Liu, Arun K Singh, Nikola Dobrilovic, William C Feng, Louis M Chu, Michael P Robich, Kamal R Khabbaz, Frank W Sellke.   

Abstract

BACKGROUND: We studied the contractile response of human peripheral microvasculature to thromboxane A-2 (TXA-2) before and after cardiopulmonary bypass (CPB), with and without the blockade of TXA-2 receptors, or the inhibition of phospholipase C (PLC), phospholipase A-2 (PLA-2) or protein kinase C (PKC)-α. We also examined the protein/gene expression and localization of TXA-2 receptors, TXA-2 synthase, PLC, and other TXA-2-related proteins.
METHODS: Skeletal muscle arterioles (90-180 μm in diameter) were harvested pre- and post-CPB from patients (n = 28) undergoing cardiac surgery.
RESULTS: The post-CPB contractile response of skeletal muscle arterioles to TXA-2 analog U-46619 was impaired compared with pre-CPB (P < .05). The presence of TXA-2 receptor antagonist SQ-29548 (10(-6)mol/L) prevented the contractile response to U-46619 (P < .05). Pretreatment with the PLC inhibitor U-73122 (10(-6)mol/L) significantly inhibited the U-46619-induced contractile response (P < .01). Administration of the PLA-2 inhibitor quinacrine (10(-6)mol/L) or PKC-α inhibitor safingol (2 × 10(-5)mol/L), however, failed to affect U-46619-induced contraction. Total protein levels and gene expression of TXA-2 receptors, and TXA-2 synthase of skeletal muscle, were not altered post-CPB. Confocal microscopy showed no differences in the expression of PLCβ-3 in the microcirculation. PLCβ-3 was localized to both smooth muscle and endothelium.
CONCLUSION: CPB decreases the contractile response of human peripheral arterioles to TXA-2 soon after cardiac surgery. This response may be in part responsible for the decrease in vascular tone, and accompanying hypotension sometimes observed after cardiac operations utilizing CPB.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21801963      PMCID: PMC3148492          DOI: 10.1016/j.surg.2011.06.004

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  19 in total

1.  Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).

Authors:  V P Addonizio; C A Fisher; J R Kappa; N Ellison
Journal:  Surgery       Date:  1987-11       Impact factor: 3.982

2.  Thromboxane synthesis and platelet secretion during cardiopulmonary bypass with bubble oxygenator.

Authors:  V P Addonizio; J B Smith; J F Strauss; R W Colman; L H Edmunds
Journal:  J Thorac Cardiovasc Surg       Date:  1980-01       Impact factor: 5.209

3.  Effects of cardiopulmonary bypass on endothelin-1-induced contraction and signaling in human skeletal muscle microcirculation.

Authors:  Jun Feng; Louis M Chu; Michael P Robich; Richard T Clements; Kamal R Khabbaz; Robert Hagberg; Yuhong Liu; Robert M Osipov; Frank W Sellke
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

4.  Serotonin-induced coronary contraction increases after blood cardioplegia-reperfusion: role of COX-2 expression.

Authors:  C Métais; J Li; M Simons; F W Sellke
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.

Authors:  W D Watkins; M B Peterson; D L Kong; K Kono; M J Buckley; F H Levine; D M Philbin
Journal:  J Thorac Cardiovasc Surg       Date:  1982-08       Impact factor: 5.209

6.  Cardiopulmonary bypass reduces peripheral microvascular contractile function by inhibition of mitogen-activated protein kinase activity.

Authors:  Tanveer A Khan; Cesario Bianchi; Eugenio G Araujo; Marc Ruel; Pierre Voisine; Jianyi Li; John R Liddicoat; Frank W Sellke
Journal:  Surgery       Date:  2003-08       Impact factor: 3.982

7.  Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.

Authors:  G C Davies; M Sobel; E W Salzman
Journal:  Circulation       Date:  1980-04       Impact factor: 29.690

8.  Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.

Authors:  M L Ogletree; D N Harris; R Greenberg; M F Haslanger; M Nakane
Journal:  J Pharmacol Exp Ther       Date:  1985-08       Impact factor: 4.030

9.  Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.

Authors:  O Ylikorkala; E Saarela; L Viinikka
Journal:  J Thorac Cardiovasc Surg       Date:  1981-08       Impact factor: 5.209

10.  Platelet loss during experimental cardiopulmonary bypass and its prevention with prostacyclin.

Authors:  J R Plachetka; N W Salomon; D F Larson; J G Copeland
Journal:  Ann Thorac Surg       Date:  1980-07       Impact factor: 4.330

View more
  6 in total

1.  Decreased contractile response of peripheral arterioles to serotonin after CPB in patients with diabetes.

Authors:  Sharif A Sabe; Jun Feng; Yuhong Liu; Laura A Scrimgeour; Afshin Ehsan; Frank W Sellke
Journal:  Surgery       Date:  2018-08       Impact factor: 3.982

2.  Changes in microvascular reactivity after cardiopulmonary bypass in patients with poorly controlled versus controlled diabetes.

Authors:  Jun Feng; Yuhong Liu; Louis M Chu; Arun K Singh; Nikola Dobrilovic; James G Fingleton; Richard T Clements; Cesario Bianchi; Frank W Sellke
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

3.  Skeletal muscle microvasculature response to β-adrenergic stimuli is diminished with cardiac surgery.

Authors:  Olivia Ziegler; Kelsey Anderson; Yuhong Liu; Afshin Ehsan; James Fingleton; Neel Sodha; Jun Feng; Frank W Sellke
Journal:  Surgery       Date:  2019-09-04       Impact factor: 3.982

4.  Cyclooxygenase 2 contributes to bradykinin-induced microvascular responses in peripheral arterioles after cardiopulmonary bypass.

Authors:  Jun Feng; Kelsey Anderson; Yuhong Liu; Arun K Singh; Afshin Ehsan; Frank W Sellke
Journal:  J Surg Res       Date:  2017-06-22       Impact factor: 2.192

5.  Impaired coronary contraction to phenylephrine after cardioplegic arrest in diabetic patients.

Authors:  Nicholas Sellke; Caroline Gordon; Isabella Lawandy; Anastassia Y Gorvitovskaia; Laura A Scrimgeour; James G Fingleton; Frank W Sellke; Jun Feng
Journal:  J Surg Res       Date:  2018-05-22       Impact factor: 2.192

6.  Decreased coronary arteriolar response to KCa channel opener after cardioplegic arrest in diabetic patients.

Authors:  Yuhong Liu; Victoria Cole; Isabella Lawandy; Afshin Ehsan; Frank W Sellke; Jun Feng
Journal:  Mol Cell Biochem       Date:  2018-01-05       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.